Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-12-18 00:00:00 ET · period of report 2024-12-16 · accession 0001968202-24-000142 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-18 | 2024-12-16 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $730.81 | -969 | 34.8K | -3% | -$708.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-16 | F | D | 969 | $730.81 | 34,792 | D | — | — |